Welcome
Support Centre
11 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Randomised, Double-Blind, Placebo Controlled, Cross Over Trial of a Parenteral Modified Cobratoxin in Adrenomyeloneuropathy
ISRCTN ISRCTN48334111
ClinicalTrials.gov identifier
Public title Randomised, Double-Blind, Placebo Controlled, Cross Over Trial of a Parenteral Modified Cobratoxin in Adrenomyeloneuropathy
Scientific title
Acronym MCTX in Adrenomyeloneuropathy
Serial number at source AMN002
Study hypothesis Not provided at time of registration.
Lay summary
Ethics approval Not provided at time of registration.
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Adrenomyeloneuropathy (AMN)
Participants - inclusion criteria 1. Male or female age ≥18 years
2. Diagnosis of AMN either biochemically or genetically
3. Have some motor disability that affects their gait
4. Willing and able to provide written informed consent
5. Willing and able to comply with study procedures
Participants - exclusion criteria Not provided at time of registration.
Anticipated start date 10/03/2000
Anticipated end date 10/03/2003
Status of trial Completed
Patient information material
Target number of participants Not provided at time of registration.
Interventions Modified cobratoxin (0.25 mg) administered subcutaneously (sc) twice daily for 6 months versus placebo injections.
Primary outcome measure(s) Not provided at time of registration.
Secondary outcome measure(s) Not provided at time of registration.
Sources of funding ReceptoPharm Inc.
Trial website
Publications 2003 results in http://www.ncbi.nlm.nih.gov/pubmed/12939429
Contact name Dr  Phillip  Lee
  Address National Hospital for Neurology and Neurosurgery
Queens Square
  City/town London
  Zip/Postcode WC1N 3BG
  Country United Kingdom
Sponsor ReceptoPharm Inc. (USA)
  Address 1537 NW 65th Ave
  City/town Plantation
  Zip/Postcode 33313
  Country United States of America
  Tel +1 954 321 8988
  Fax +1 954 321 9778
  Email receptin@bellsouth.net
Date applied 04/01/2005
Last edited 17/11/2010
Date ISRCTN assigned 10/03/2005
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central